BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31621203)

  • 1. Carbon-ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study.
    Takayasu Y; Kubo N; Shino M; Nikkuni O; Ida S; Musha A; Takahashi K; Hirato J; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T; Nakano T;
    Cancer Med; 2019 Dec; 8(17):7227-7235. PubMed ID: 31621203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study.
    Umeda Y; Yoshikawa S; Kiniwa Y; Maekawa T; Yamasaki O; Isei T; Matsushita S; Nomura M; Nakai Y; Fukushima S; Saito S; Takenouchi T; Tanaka R; Kato H; Otsuka A; Matsuya T; Baba N; Nagase K; Inozume T; Onuma T; Kuwatsuka Y; Fujimoto N; Kaneko T; Onishi M; Namikawa K; Yamazaki N; Nakamura Y
    Eur J Cancer; 2021 Nov; 157():361-372. PubMed ID: 34563991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter Study of Carbon-Ion Radiation Therapy for Mucosal Melanoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).
    Koto M; Demizu Y; Saitoh JI; Suefuji H; Tsuji H; Okimoto T; Ohno T; Shioyama Y; Takagi R; Nemoto K; Nakano T; Kamada T;
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1054-1060. PubMed ID: 28332989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of mucosal melanoma of the head and neck.
    Frakes JM; Strom TJ; Naghavi AO; Trotti A; Rao NG; McCaffrey JC; Otto KJ; Padhya T; Caudell JJ
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):268-73. PubMed ID: 26597431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral mucosal melanoma treated with carbon ion radiotherapy: a case report.
    Musha A; Saitoh JI; Shirai K; Yokoo S; Ohno T; Nakano T
    J Med Case Rep; 2016 Oct; 10(1):284. PubMed ID: 27756356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-Modulated Proton and Carbon-Ion Radiation Therapy in the Management of Head and Neck Sarcomas.
    Yang J; Gao J; Qiu X; Hu J; Hu W; Wu X; Zhang C; Ji T; Kong L; Lu JJ
    Cancer Med; 2019 Aug; 8(10):4574-4586. PubMed ID: 31231939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
    Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
    Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Phase 1/2 ACCEPT Trial: Concurrent Cetuximab and Intensity Modulated Radiation Therapy with Carbon Ion Boost for Adenoid Cystic Carcinoma of the Head and Neck.
    Adeberg S; Akbaba S; Lang K; Held T; Verma V; Nikoghosyan A; Bernhardt D; Münter M; Freier K; Plinkert P; Hauswald H; Herfarth K; Rieken S; Debus J; Jensen AD
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):167-173. PubMed ID: 31586664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
    Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
    Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
    Seiwert TY; Melotek JM; Blair EA; Stenson KM; Salama JK; Witt ME; Brisson RJ; Chawla A; Dekker A; Lingen MW; Kocherginsky M; Villaflor VM; Cohen EE; Haraf DJ; Vokes EE
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):21-9. PubMed ID: 27511844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
    Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
    Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy.
    Yanagi T; Mizoe JE; Hasegawa A; Takagi R; Bessho H; Onda T; Kamada T; Okamoto Y; Tsujii H
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):15-20. PubMed ID: 19046826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies.
    Gao J; Hu J; Guan X; Yang J; Hu W; Kong L; Lu JJ
    Sci Rep; 2019 Mar; 9(1):4259. PubMed ID: 30862843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Particle therapy for mucosal melanoma of the head and neck. A single-institution retrospective comparison of proton and carbon ion therapy.
    Demizu Y; Fujii O; Terashima K; Mima M; Hashimoto N; Niwa Y; Akagi T; Daimon T; Murakami M; Fuwa N
    Strahlenther Onkol; 2014 Feb; 190(2):186-91. PubMed ID: 24362502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer.
    Allal AS; Zwahlen D; Becker M; Dulguerov P; Mach N
    Cancer J; 2006; 12(1):63-8. PubMed ID: 16613664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution.
    Sun S; Huang X; Gao L; Zhang Y; Luo J; Zhang S; Wang K; Qu Y; Wu R; Liu Q; Xiao J; Xu G; Yi J
    Oral Oncol; 2017 Nov; 74():115-122. PubMed ID: 29103739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective observational study of carbon-ion radiotherapy for non-squamous cell carcinoma of the head and neck.
    Shirai K; Saitoh JI; Musha A; Abe T; Kobayashi D; Takahashi T; Tamaki T; Kawamura H; Takayasu Y; Shino M; Toyoda M; Takahashi K; Hirato J; Yokoo S; Chikamatsu K; Ohno T; Nakano T;
    Cancer Sci; 2017 Oct; 108(10):2039-2044. PubMed ID: 28730646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.
    Temam S; Mamelle G; Marandas P; Wibault P; Avril MF; Janot F; Julieron M; Schwaab G; Luboinski B
    Cancer; 2005 Jan; 103(2):313-9. PubMed ID: 15578718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle radiotherapy using protons or carbon ions for unresectable locally advanced head and neck cancers with skull base invasion.
    Morimoto K; Demizu Y; Hashimoto N; Mima M; Terashima K; Fujii O; Otsuki N; Murakami M; Fuwa N; Nibu K
    Jpn J Clin Oncol; 2014 May; 44(5):428-34. PubMed ID: 24620027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy: prognostic value of pretreatment apparent diffusion coefficient (ADC).
    Jingu K; Kishimoto R; Mizoe JE; Hasegawa A; Bessho H; Tsuji H; Kamada T; Yamada S; Tsujii H
    Radiother Oncol; 2011 Jan; 98(1):68-73. PubMed ID: 20951452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.